Markus Vogt

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elmar Wolf · 2 shared papers, 2024–2026 · strength 0.36
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
   • Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
2. Sven‐Thorsten Liffers · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
3. Diana Behrens · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
4. Juanfei Peng · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
5. Phyllis F. Cheung · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
6. Marija Trajkovic‐Arsic · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
7. Barbara T. Grünwald · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
8. Niklas Krebs · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
9. Laura Godfrey · 1 shared paper, 2026 · strength 0.20
   • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
10. Rita Teresa Lawlor · 1 shared paper, 2026 · strength 0.20
    • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
11. Jens Thomas Siveke · 1 shared paper, 2026 · strength 0.20
    • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
12. Rickmer Braren · 1 shared paper, 2026 · strength 0.20
    • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
13. Aldo Scarpa · 1 shared paper, 2026 · strength 0.20
    • Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
14. Mathias Tillmann Rosenfeldt · 1 shared paper, 2024 · strength 0.16
    • Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
15. Martin Eilers · 1 shared paper, 2024 · strength 0.16
    • Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
16. Dieter Saur · 1 shared paper, 2024 · strength 0.16
    • Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.